LncRNA CHROMR suppression (Fig. 10, D and E) significantly reduced mRNA and protein levels of MET, whereas CHROMR overexpression (Fig. 10, F and G) enhanced MET levels in DLBCL cells. The gene discussed is CHROMR; the disease is diffuse large B-cell lymphoma.